The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.

Through Friday, with the latest quarterly results in from more than three-fifths of the S&P 500, 77% have turned in earnings per share higher than analysts expected, according to FactSet.

Vertex Pharmaceuticals ( VRTX) reported fourth-quarter revenue and offered an outlook for 2025 that topped analysts’ expectations. The company said it anticipates 2025 revenue of $11.75 billion to $12 ...

(NASDAQ: MNDY), the multi-product platform that runs all core aspects of work, today reported financial results for its fourth quarter and ...

Report with market evolution powered by AI - The global REIT market size is estimated to grow by USD 350.2 billion ...

Good day, everyone, and welcome to the i3 Verticals First Quarter 2025 Earnings Conference Call. Today's call is being recorded and the replay will be available starting today through February 14. A ...

Ladies and gentlemen, welcome to the Cognizant Technology Solutions’ Fourth Quarter 2024 Earnings Conference Call. All lines ...

Seeing “growth on hiatus,” Mr. Bir reduced his own forecast for 2025 and 2026 “with revisions mainly for longer lease-up ...

Thank you for standing by, and welcome to PTC's 2025 first quarter conference call. [Operator instructions] I would now like to turn the call over to Matt Shimao, PTC's head of investor relations.

Q1 2025 Earnings Conference Call February 3, 2025 8:00 AM ETCompany ParticipantsTigran Karapetian - Head of IRRuy Cunha ...

SPRINGDALE, Ark., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Tyson Foods, Inc. (NYSE: TSN), one of the world’s largest food companies and a recognized leader in protein with leading brands including Tyson, ...

C3309C STMicroelectronics Reports Q4 and FY 2024 Financial ResultsQ4 net revenues $3.32 billion; gross margin 37.7%; operating margin ...